Rebbeck, Timothy R.; Mitra, Ruchira; Wan, F.; Sinilnikova, Olga M.; Healey, Sue; McGuffog, Lesley; Chenevix-Trench, Georgia; Easton, Douglas F.; Antoniou, Antonis C.; Nathanson, Katherine L.; Laitman, Yael; Kushnir, A.; Paluch-Shimon, S.; Berger, R.; Zidan, Jamal; Friedman, Eitan; Ehrencrona, Hans; Stenmark-Askmalm, Marie; Einbeigi, Zakaria; Loman, Niklas; Harbst, K.; Rantala, Johanna; Melin, B.; Huo, Dezheng; Olopade, O.I.; Seldon, J.; Ganz, Patricia A.; Nussbaum, Robert L.; Chan, S.B.; Odunsi, Kunle; Gayther, Simon; Domchek, Susan M.; Arun, Banu K.; Lu, Karen H.; Mitchell, Graham; Karlan, Beth Y.; Walsh, Christine; Lester, Jenny; Godwin, Andrew K.; Pathak, H.,; Ross, E.; Daly, Mary B.; Whittemore, Alice S.; John, Esther M.; Miron, Alexander; Terry, Mary Beth; Chung, Wendy K.; Goldgar, David E.; Buys, Saundra S.; Janavičius, R.; Tihomirova, Laima; Tung, Nadine; Dorfling, Cecilia Maria; Jansen van Rensburg, Elizabeth
(American Medical Association, 2015-04)
IMPORTANCE : Limited information about the relationship between specific mutations in
BRCA1 or BRCA2 (BRCA1/2) and cancer risk exists.
OBJECTIVE : To identify mutation-specific cancer risks for carriers of BRCA1/2.
DESIGN, ...
